Questions over remdesivir
The Financial Times said — citing documents accidentally published by the World Health Organization — that Gilead Sciences' drug remdesivir did not improve patients' condition or reduce the coronavirus pathogen in their bloodstream. Those findings, according to the report, came from a clinical trial in China. Gilead took exception with the report, saying: "it was underpowered to enable statistically meaningful conclusions.
レムデシビルに関する質問 フィナンシャルタイムズ紙は、世界保健機関が誤って発行した文書を引用して、ギリアドサイエンスの薬物レムデシビルが患者の状態を改善したり、血流中のコロナウイルス病原体を減らしたりしなかったと述べました。レポートによると、これらの
Financial times manipulated the market with a report from the corrupt ,dishonest and now defunded WHO. On a study , now get this , done in China. The country that made and released the cirus ,then lied about it. Causing thousands of deaths. THAT is who they choose to believe?
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
Källa: MarketWatch - 🏆 3. / 97 Läs mer »
Källa: BusinessInsider - 🏆 729. / 51 Läs mer »